BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen T, Hu Y, Liu B, Huang X, Li Q, Gao N, Jin Z, Jia T, Guo D, Jin G. Combining thioridazine and loratadine for the treatment of gastrointestinal tumor. Oncol Lett 2017;14:4573-80. [PMID: 29085455 DOI: 10.3892/ol.2017.6815] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Zhou S, Huang G, Chen G. The antagonistic activity of H1 receptor antagonists as medicinal foods. Trends in Food Science & Technology 2020;105:1-16. [DOI: 10.1016/j.tifs.2020.08.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
2 Fritz I, Wagner P, Olsson H. Improved survival in several cancers with use of H1-antihistamines desloratadine and loratadine. Transl Oncol 2021;14:101029. [PMID: 33550204 DOI: 10.1016/j.tranon.2021.101029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Ellegaard AM, Bach P, Jäättelä M. Targeting Cancer Lysosomes with Good Old Cationic Amphiphilic Drugs. Rev Physiol Biochem Pharmacol 2021. [PMID: 33398504 DOI: 10.1007/112_2020_56] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Hendouei N, Saghafi F, Shadfar F, Hosseinimehr SJ. Molecular mechanisms of anti-psychotic drugs for improvement of cancer treatment. Eur J Pharmacol 2019;856:172402. [PMID: 31108054 DOI: 10.1016/j.ejphar.2019.05.031] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
5 Lin X, Zhang J, Wang X, Lin G, Chen T. Pre-activation with TLR7 in combination with thioridazine and loratadine promotes tumoricidal T-cell activity in colorectal cancer. Anticancer Drugs 2020;31:989-96. [PMID: 32694422 DOI: 10.1097/CAD.0000000000000972] [Reference Citation Analysis]
6 Stone EA, Cutrona KJ, Miller SJ. Asymmetric Catalysis upon Helically Chiral Loratadine Analogues Unveils Enantiomer-Dependent Antihistamine Activity. J Am Chem Soc 2020;142:12690-8. [PMID: 32579347 DOI: 10.1021/jacs.0c03904] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
7 Zheng J, Shang Y, Wu Y, Zhao Y, Chen Z, Lin Z, Li P, Sun X, Xu G, Wen Z, Chen J, Wang Y, Wang Z, Xiong Y, Deng Q, Qu D, Yu Z. Loratadine inhibits Staphylococcus aureus virulence and biofilm formation. iScience 2022;25:103731. [DOI: 10.1016/j.isci.2022.103731] [Reference Citation Analysis]
8 Zhou Y, Gao C, Wang H, Liu L, Huang Z, Fa X. Histamine H1 type receptor antagonist loratadine ameliorates oxidized LDL induced endothelial dysfunction. Biomedicine & Pharmacotherapy 2018;106:1448-53. [DOI: 10.1016/j.biopha.2018.07.025] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
9 Chen T, Li L, Lin X, Yang Z, Zou W, Chen Y, Xu J, Liu D, Wang X, Lin G. In vitro and in vivo immunotoxicity of PEGylated Cd-free CuInS 2 /ZnS quantum dots. Nanotoxicology 2020;14:372-87. [DOI: 10.1080/17435390.2019.1708495] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
10 Herranz C, Mateo F, Baiges A, Ruiz de Garibay G, Junza A, Johnson SR, Miller S, García N, Capellades J, Gómez A, Vidal A, Palomero L, Espín R, Extremera AI, Blommaert E, Revilla-López E, Saez B, Gómez-Ollés S, Ancochea J, Valenzuela C, Alonso T, Ussetti P, Laporta R, Xaubet A, Rodríguez-Portal JA, Montes-Worboys A, Machahua C, Bordas J, Menendez JA, Cruzado JM, Guiteras R, Bontoux C, La Motta C, Noguera-Castells A, Mancino M, Lastra E, Rigo-Bonnin R, Perales JC, Viñals F, Lahiguera A, Zhang X, Cuadras D, van Moorsel CHM, van der Vis JJ, Quanjel MJR, Filippakis H, Hakem R, Gorrini C, Ferrer M, Ugun-Klusek A, Billett E, Radzikowska E, Casanova Á, Molina-Molina M, Roman A, Yanes O, Pujana MA. Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis. EMBO Mol Med 2021;:e13929. [PMID: 34378323 DOI: 10.15252/emmm.202113929] [Reference Citation Analysis]